Background : Bendamustine, a bifunctional alkylating agent with anticipated purin-like properties is active in metastatic breast cancer (MBC) patients.

苯达莫司汀，具有烷化剂和嘌的双相能可以性乳腺癌（MBC）患者中发挥作用。